Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical case definition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome.
Manosuthi W, Van Tieu H, Mankatitham W, Lueangniyomkul A, Ananworanich J, Avihingsanon A, Siangphoe U, Klongugkara S, Likanonsakul S, Thawornwan U, Suntisuklappon B, Sungkanuparph S; N2R Study Team. Manosuthi W, et al. Among authors: mankatitham w. AIDS. 2009 Nov 27;23(18):2467-71. doi: 10.1097/QAD.0b013e32832f7b59. AIDS. 2009. PMID: 19898217
Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: results from the TIME study.
Manosuthi W, Mankatitham W, Lueangniyomkul A, Thongyen S, Likanonsakul S, Suwanvattana P, Thawornwan U, Suntisuklappon B, Nilkamhang S, Sungkanuparph S; TIME Study Team. Manosuthi W, et al. Among authors: mankatitham w. J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):377-83. doi: 10.1097/QAI.0b013e31825b5e06. J Acquir Immune Defic Syndr. 2012. PMID: 22592586 Clinical Trial.
Incidence and risk factors of nevirapine-associated skin rashes among HIV-infected patients with CD4 cell counts <250 cells/microL.
Manosuthi W, Sungkanuparph S, Tansuphaswadikul S, Inthong Y, Prasithsirikul W, Chottanapund S, Mankatitham W, Chimsuntorn S, Sittibusaya C, Moolasart V, Chumpathat N, Termvises P, Chaovavanich A. Manosuthi W, et al. Among authors: mankatitham w. Int J STD AIDS. 2007 Nov;18(11):782-6. doi: 10.1258/095646207782212289. Int J STD AIDS. 2007. PMID: 18005514
A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study.
Manosuthi W, Sungkanuparph S, Tantanathip P, Lueangniyomkul A, Mankatitham W, Prasithsirskul W, Burapatarawong S, Thongyen S, Likanonsakul S, Thawornwa U, Prommool V, Ruxrungtham K; N2R Study Team. Manosuthi W, et al. Among authors: mankatitham w. Clin Infect Dis. 2009 Jun 15;48(12):1752-9. doi: 10.1086/599114. Clin Infect Dis. 2009. PMID: 19438397 Clinical Trial.
Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampin.
Manosuthi W, Sungkanuparph S, Tantanathip P, Mankatitham W, Lueangniyomkul A, Thongyen S, Eampokarap B, Uttayamakul S, Suwanvattana P, Kaewsaard S, Ruxrungtham K; N2R Study Team. Manosuthi W, et al. Among authors: mankatitham w. Antimicrob Agents Chemother. 2009 Oct;53(10):4545-8. doi: 10.1128/AAC.00492-09. Epub 2009 Aug 10. Antimicrob Agents Chemother. 2009. PMID: 19667281 Free PMC article.
Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients.
Manosuthi W, Sukasem C, Lueangniyomkul A, Mankatitham W, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S. Manosuthi W, et al. Among authors: mankatitham w. Antimicrob Agents Chemother. 2013 Feb;57(2):1019-24. doi: 10.1128/AAC.02023-12. Epub 2012 Dec 17. Antimicrob Agents Chemother. 2013. PMID: 23254426 Free PMC article.
CYP2B6 haplotype and biological factors responsible for hepatotoxicity in HIV-infected patients receiving efavirenz-based antiretroviral therapy.
Manosuthi W, Sukasem C, Lueangniyomkul A, Mankatitham W, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S. Manosuthi W, et al. Among authors: mankatitham w. Int J Antimicrob Agents. 2014 Mar;43(3):292-6. doi: 10.1016/j.ijantimicag.2013.10.022. Epub 2013 Nov 25. Int J Antimicrob Agents. 2014. PMID: 24359841
11 results